Staphylococcus aureus (S. aureus) possesses high host-specificity, including many human-27 specific virulence factors. Current efforts towards vaccine development have largely failed, 28 citing inappropriate infection models and insufficient understanding of staphylococcal 29 virulence. We sought to create a humanised zebrafish infection model susceptible to human-30 specific virulence factors, focusing on the human C5a receptor (C5AR1) which is targeted by 31 three human-specific staphylococcal virulence factors, CHIPS, PVL, and HlgCB. We 32 demonstrated that the zebrafish C5a receptor (C5aR) responds to serum-derived zebrafish 33
Host-specialisation is a major trait observed in many bacterial pathogens and represents a 42 major obstacle towards understanding infection in vivo (Bäumler and Fang, 2013) . Among 43 these host-specific pathogens is the gram-positive opportunistic pathogen Staphylococcus 44 aureus, which colonises 30% of the human population and causes a variety of mild to severe 45 illnesses ranging from skin and soft-tissue infections to necrotising pneumonia, endocarditis 46 and septicaemia (Hersh et al., 2008; Graves et al., 2010; Kallen, 2010; Federspiel et al., 2012) . 47
In the USA, as many as 50% of S. aureus infections are caused by antibiotic-resistant strains 48 (Moran et al., 2006) , with methicillin-resistant S. aureus (MRSA) among the leading causes of 49 death by a single infectious agent (Klevens et al., 2007) , emphasising a need for alternative 50 therapies. Despite promising results from in vivo studies targeting bacterial surface 51 components and toxins (Shinefield et al., 2002; Weems et al., 2006; Moustafa et al., 2012; 52 Fowler et al., 2013), these targets have largely failed to translate from traditional infection 53 models into humans. This is attributed to the variety of virulence factors S. aureus uses to 54 evade the immune system, as well as shortcomings that exist in current infection models 55 (Mestas and Hughes, 2004 ; Salgado-Pabón and Schlievert, 2014a). 56
Many of these virulence factors exhibit a high degree of human specificity, notably, a single 57 amino acid change in the secreted chemotaxis inhibitor CHIPS causes as much as a 100-fold 58 loss in binding affinity to its target receptor in vitro (Haas et al., 2004a) . These virulence factors 59 perform many different functions that enhance bacterial virulence and many broadly target the 60 host innate immune system to impair the complement system, oxidative enzymes, 61 chemotactic proteins and phagocytic cells in order to evade recognition and destruction (de Three S. aureus virulence factors interact with the human C5a receptor (C5AR1, CD88), a 64 seven-transmembrane loop G-protein coupled receptor (GPCR) that is highly expressed on 65 the surface of neutrophils (Laumonnier et al., 2017) and recognises host anaphylatoxin C5a 66 4 released during complement activation to control phagocyte activation and chemotaxis. The 67 targeting of C5AR1 by multiple S. aureus virulence factors would appear to be specifically 68 focused against neutrophils, which form an essential line of defence against staphylococcal 69 infection (Spaan et al., 2013b) . The chemotaxis inhibitory protein of S. aureus (CHIPS) is a 14 70 kDa protein that prevents C5a-mediated chemotaxis by binding directly to the N-terminus of 71 C5AR1 (Haas et al., 2004b) . In addition, the two bicomponent pore-forming toxins Valentine Leukocidin (PVL) and γ-Haemolysin CB (HlgCB) target C5AR1 to recognise and 73 lyse phagocytic cells by forming β-barrel pores in the cell surface (Spaan et al., 2013a (Spaan et al., , 2014 . 74
These toxins are secreted in two subunits, known as the S-(slow, LukS-PV/HlgC) and F-(fast, 75
LukF-PV/HlgB) subunits due to their chromatography elution profiles. Besides inducing cell 76 lysis, S-subunits also disrupt chemotactic signalling by competitively inhibiting receptor 77 signalling in a manner resembling CHIPS (Spaan et al., 2013a (Spaan et al., , 2014 . The high-affinity 78 protein-protein interactions between virulence factors and C5AR1 at the amino-acid level 79 produce a highly human-specific interaction and, consequently, understanding of the roles that 80 they play during infection is limited due to a lack of suitable humanised infection models 81 (Proctor, 2012 vector expresses the cloned transgene from an EF1A promoter as well as the fluorescent 115 protein mAmetrine and the selection marker ZeoR from the PGK promoter. Third generation 116 lentiviral particles were produced in HEK293T cells following standard lentivirus production 117 methods. Spin infection of U937 cells was performed by adding 100 µl virus supernatant with 118 8 µg/mL polybrene to 50.000 cells and spinning at 1000g for 2 h at 33 °C. Transduced cell 119 lines were selected to high purity (>95%) by selection with 400 µg/ml Zeocin starting two days 120 post transduction, and transgene expression was confirmed by flow cytometry using a mouse 121 anti-FLAG M2 antibody (F1804, Sigma-Aldrich) together with an APC or PE-conjugated 122 secondary anti-mouse antibody (Jackson) and acquisition on a FACSCantoII (BD Bioscience) 123 cytometer. For expression of the zebrafish C5a receptor the full-length mRNA coding 124 sequence was used (XM_005159274.1). 125 
Recombinant protein production and FITC labelling

Injection of the zebrafish otic vesicle
198 1% agarose dishes supplemented with E3 were cast using the triangular moulds described in 199 (Bernut et al., 2015) . Before injection, larvae were anaesthetised by immersion in 0.02% (w/v) 200
Tricaine prior to transfer to the mounting dish. Larvae were then arranged laterally in rows. 201
Excess media was then removed with a pipette to minimise movement during injection. Larvae 202 were then injected from the dorsal side into the otic vesicle. Four hours after injection, larvae 203 were fixed for 1 hour in 4% paraformaldehyde, and later stained with Sudan Black B to indicate 204 neutrophils. Proteins were injected at the highest available concentration, which were 10µM 205 and 90µM for hsaC5a (human) and dreC5a (zebrafish) respectively, and 30.3µM and 16.7µM 206 for PVL and HlgCB respectively. 207 208
Systemic infection of zebrafish embryos and irf8 knockdown 209
Zebrafish larvae at 30 or 54 hpf were microinjected into the circulation with bacteria as 210 previously described (Prajsnar et al., 2008) . Briefly, anaesthetised larvae were embedded in 211 3% w/v methylcellulose and injected individually with 1 nl using microcapillary pipettes filled 212 with the bacterial suspension of known concentration. Following infection, larvae were 213 observed frequently up to 122 hpf and numbers of dead larvae recorded at each time point. 214
Morpholino-modified antisense oligomer against and irf8 (splice MO) (Li et al., 2011) was 215 injected using a method described previously (Prajsnar et al., 2008) . Zebrafish and human C5a-C5aR signalling is species specific 236 To study the C5a-C5aR signalling axis in zebrafish, we first expressed the zebrafish C5a 237 receptor (c5ar1) in the human monocyte-like cell line U937 (U937-dreC5aR) by lentiviral 238 transduction ( Figure 1A ), and measured the receptor's ability to bind and respond to 239 recombinant zebrafish and human C5a (dreC5a/hsaC5a) using previously established 240 methods (Spaan et al., 2013a) . For clarity, human C5a will be referred to as 'hsaC5a', and 241 zebrafish C5a as 'dreC5a'. As controls, we generated cells stably expressing the human C5a 242 receptor (U937-hsaC5aR), or an empty vector control (U937-EV). Firstly, flow-cytometric 243 analysis of recombinant, FITC-labelled C5a-binding capacities showed that U937-dreC5aR 244 cells specifically bound dreC5a, but not hsaC5a ( Figure 1B) . Conversely, U937-hsaC5aR cells 245 strongly bound hsaC5a and only marginally interacted with dreC5a, suggesting that both 246 receptors retain the ability to bind C5a in a species-specific manner. Activation of GPCRs, 247
including the C5a receptor, results in the activation of intracellular signalling cascades 248 culminating in the cytosolic release of intracellular calcium stores (Tawk et al., 2015) . 249 Accordingly, we evaluated the signalling ability of the receptors by measuring intracellular Ca 2+ 250 release following receptor stimulation using the Fluo-3AM probe. Treatment of U937-dreC5aR 251 cells with recombinant dreC5a resulted in robust calcium release, indicative of successful 252 receptor ligation and activation, whereas U937-hsaC5aR expressing cells responded 253 minimally to dreC5a ( Figure 1C ). Importantly, zymosan-activated zebrafish serum induced a 254 response similar to recombinant C5a, indicating that the zebrafish C5aR responds to 255 physiological concentrations of zebrafish C5a in activated fish serum under these conditions. 256
Conversely, U937-hsaC5aR cells responded robustly to hsaC5a or human activated serum 257 treatment, but not dreC5a treatment. Taken together, these data show the zebrafish c5ar1 258 gene encodes a functional surface receptor that interacts with, and is activated by, 259 physiological concentrations of C5a. Furthermore, the human and zebrafish C5a receptor and 260 ligand pairs are species specific and are not interchangeable. 261 12 262 Zebrafish C5aR is not targeted by human-specific virulence factors 263 The three S. aureus C5AR1-targeting virulence factors, CHIPS, PVL, and HlgCB, are known 264 to display strict human specificity and are unable to interact with C5aR's expressed by several 265 other species (Spaan et al., 2013a (Spaan et al., , 2014 . However, their ability to target zebrafish 266 complement components is unknown. Therefore, we first assessed the functionality of the 267 zebrafish C5a receptor in the absence and presence of the inhibitory protein CHIPS. We 268 observed that U937-dreC5aR cells retained complete signalling ability in the presence of 269 CHIPS at concentrations that completely inhibited U937-hsaC5aR cells, indicating that CHIPS 270 is ineffective at targeting the zebrafish receptor ( Figure 2A ). Furthermore, addition of purified, 271 recombinant leukocidin components to U937-dreC5aR cells showed that these cells were 272 insensitive to concentrations of PVL and HlgCB that readily permeabilised U937-hsaC5aR 273 cells ( Figure 2B that the C5AR1-Clover protein is expressed specifically in zebrafish neutrophils ( Figure 3A,B) . 293
While mCherry showed general cytoplasmic localisation, the C5AR1-associated Clover signal 294 was enriched at the cell membrane of neutrophils from Tg(lyz:hsaC5aR1-Clover)sh505 295 zebrafish, suggesting that the cell-surface expression of C5AR1 observed in human 296 neutrophils is correctly recapitulated in the humanised zebrafish system ( Figure 3C,D) . 297
Notably, the total number of neutrophils in these fish was unaffected by transgene expression 298 ( Figure S2 of hsaC5a did not affect neutrophil migration (Fig. 4A, B) . In contrast, expression of the human 308 C5AR1 transgene in zebrafish neutrophils conferred the ability to migrate towards hsaC5a, 309
showing that C5AR1 acts as a functional C5a receptor in zebrafish neutrophils that can direct 310 neutrophil migration. 311 312 14 Zebrafish neutrophils expressing human C5AR1 are more susceptible to S. 313 aureus infection 314 As human C5AR1 acted as a functional receptor in our zebrafish model and was targeted by 315 human-specific virulence factors in vitro, we next asked whether neutrophil-specific 316 expression of hsaC5aR increases the susceptibility of humanised fish to staphylococcal 317 infection. To investigate this, we first separated fish into non-humanised (lyz:nfsB-mCherry 318 only) and humanised (lyz:hsaC5AR1-Clover; lyz:nfsB-mCherry) groups and injected the 319 community-acquired MRSA strain USA300 into the circulation valley of the fish at 30hpf 320 according to previously published methods (Prajsnar et al., 2008) . Initially, we observed no 321 difference in mortality between C5AR1-positive and -negative fish ( Figure 5A ). However, in 322 previous work, it was described that bacteria present in the zebrafish circulation are 323 predominantly phagocytosed and cleared by macrophages, while neutrophils phagocytose 324 surface-associated bacteria at other sites (Colucci-Guyon et al., 2011). To specifically study 325 the effect of humanised neutrophils in clearing S. aureus from the fish circulation, we silenced 326 irf8 expression using an irf8 morpholino to alter zebrafish haematopoiesis and induce the 327 differentiation of macrophages into neutrophils (Li et al., 2011) . This results in zebrafish with 328 a neutrophil-replete phenotype and minimal macrophage presence. By performing the same 329 experiment in these neutrophil-replete zebrafish, we found that C5AR1-positive zebrafish were 330 significantly more susceptible to staphylococcal infection than C5AR1-negative fish, both 331 when infected at 30hpf or 50hpf ( Figure 5B,C) . Taken together, this suggests that expression 332 of human C5AR1 in zebrafish neutrophils enhances susceptibility to staphylococcal infection. 333
334
Humanised zebrafish neutrophils are targeted by PVL and HlgCB
335
Having established that human C5AR1 expression in zebrafish neutrophils confers sensitivity 336 to S. aureus infection, we next investigated whether C5AR1-expressing neutrophils are 337 targeted by the human-specific S. aureus toxins PVL and HlgCB in vivo. To this end, the 338 community-acquired MRSA strain USA300 was injected with or without recombinant PVL into 339 15 the otic vesicle of wild type or C5AR1-transgenic larvae, and the number of neutrophils present 340 at the injection site was determined 4 hours later. Whereas injection of USA300 alone resulted 341 in similar numbers of neutrophils at the injection site in both C5AR1 negative and positive 342 larvae, the addition of PVL significantly reduced neutrophil numbers specifically in C5AR1-343 expressing larvae, while not affecting C5AR1-negative fish (Figure 6A,B ). This showed that 344 C5AR1 expression sensitises zebrafish neutrophils to PVL in vivo. Similarly, we observed a 345 reduced number of neutrophils at the injection site in humanised larvae injected with 346 USA300+HlgCB (Figure 6C on the presence of two O-sulfated tyrosine residues (Y11, Y14), four aspartic acid residues (D10, 365 D15, D18, D21) which maintain a turn motif with CHIPS and stabilise hydrogen bonding, and two 366 16 leucine residues (L20, L22) which support hydrogen bonding and possess side chains that are 367 in direct contact with the β-sheet surface of CHIPS (Chen et al., 1998; Ippel et al., 2009 ). We 368 next aimed to harness this detailed knowledge of the CHIPS targeting site on C5AR1 to 369 introduce minimal changes in dreC5aR to confer targeting by CHIPS while retaining normal 370 receptor physiology. Notably, this may be complicated by the fact that hsaC5a also interacts 371 with the receptor N-terminus (as well as the core region) via its C-terminal domain (Gerard 372 and Gerard, 1994) , suggesting that N-terminal changes in the CHIPS binding site may affect 373 the ability of the receptor to respond to its dreC5a ligand. We therefore generated 10 variant 374 dreC5aR receptors with 'human' residues in key regions of the CHIPS interaction site (Figures 375 7A). All variants maintained surface expression upon introduction into U937 cells ( Figure S1 ) 376 and all, with the exception of the fully humanised control, retained responsiveness to dreC5a 377 similar to the wild type dreC5aR ( Figure 7B ). Importantly, two receptor variants (H and I, in 378 addition to the fully humanised receptor), gained susceptibility to CHIPS-mediated inhibition 379 of signalling upon recombinant dreC5a treatment (Fig. 7C) . The presence of Y11, D21 and L22 380 was enough to confer targeting ( Figure 7C and macrophages (Ricklin et al., 2010) . We demonstrate for the first time that the zebrafish 405 C5a receptor (dreC5aR) acts as a functional G-protein coupled receptor in zebrafish and binds 406 C5a in a host-specific manner. We determined that recombinant C5a and zymosan-activated 407 zebrafish serum induces a comparable level of receptor signalling in c5ar1-expressing cells, 408
indicating that receptor activation occurs at physiological levels of C5a. Additionally, we 409 observed that zebrafish neutrophils are recruited to zebrafish C5a, suggesting that the 410 dreC5a-dreC5aR signalling axis mediates neutrophil chemotaxis in zebrafish. 411
As a gain-of-function approach, we then expressed the human C5a receptor (C5AR1) in 412 zebrafish neutrophils, establishing the transgenic line Tg(lyz:hsaC5AR1-Clover)sh505. 413 C5AR1 was functionally expressed on the surface of humanised zebrafish neutrophils, and 414 conferred responsiveness to human C5a, indicating that it acts as a functioning receptor in the 415 zebrafish. Interestingly, double transgenic neutrophils were also observed migrating to 416 zebrafish C5a, most likely due to signalling by the endogenous dreC5aR that remains intact 417 in these fish. In addition to recruitment to hsaC5a, C5AR1 expressing fish also became more 418 susceptible to staphylococcal infection when studied in a neutrophil-replete zebrafish. This 419 suggests that expression of C5AR1 significantly modifies the immune environment of the fish, 420 as a result of targeting by human-specific virulence factors. 421
We also observed a C5AR1-dependent reduction in the number of neutrophils at the injection 422 site, suggesting that Tg(lyz:hsaC5AR1-Clover)sh505 neutrophils are effectively targeted by 423 these toxins. We opted to inject purified proteins into the fish as it is unclear whether PVL or 424
HlgCB would be produced at sufficient levels to induce pore-formation and cell lysis in vivo, 425 however PVL is known to be produced in high quantities in abscesses (Badiou et al., 2008) . 426
A recent study showed that only the S-subunit of PVL targets C5AR1 while the F-subunit 427 targets the protein tyrosine phosphatase CD45, an enzyme present on all nucleated immune 428 cells (Tromp et al., 2018) . Neutrophil reductions were only observed in the presence of both 429 toxin components, suggesting that it is the result of cell lysis rather than inhibition of 430 chemotaxis by the toxin's S-subunit alone. The fact that we still observe targeting in a non-431 human model possessing only C5AR1 suggests that zebrafish CD45 retains sufficient 432 similarity to the human protein to confer receptor targeting by PVL. 433
To verify the host-specificity of C5AR1-targeting S. aureus virulence factors, we purified 434 CHIPS, PVL and HlgCB and co-incubated them with U937-dreC5aR cells. We observed that 435 compared with the human receptor, dreC5aR is insensitive to these virulence factors at 436 concentrations that effectively inhibited C5AR1, consistent with previous studies that 437 demonstrate their striking human specificity (Haas et al., 2004b; Spaan et al., 2013a Spaan et al., , 2014 . 438
We then aimed to identify the minimal number of amino acid changes to the dreC5aR required The zebrafish shows much potential as a tractable model for studying species-specific 463 pathogenesis. We show here, for the first time, that zebrafish have a functional C5a-C5aR 464 signalling axis that mediates neutrophil recruitment. After humanising zebrafish neutrophils 465 through transgenic expression of the human C5a receptor (C5AR1), we observed recruitment 466 to human C5a, targeting by human-specific virulence factors PVL and HlgCB, and reduced 467 survival during staphylococcal infection. Finally, we identified a variant of the zebrafish C5a 468 receptor (dreC5aR) that was susceptible to targeting by a third human-specific virulence 469 factor, CHIPS, after changing only three amino acids. These results show that highly specific In this study, we have successfully characterised the zebrafish C5a receptor, showing that it 476 signals in a species-specific manner in response to physiological concentrations of zebrafish 477
C5a. We also show that the receptor functions in a similar fashion to the human receptor on 478 the surface of zebrafish neutrophils, that it can induce neutrophil recruitment and that it is 479 insensitive to targeting by human-specific virulence factors. Conversely, we found that 480 zebrafish neutrophils expressing the human receptor are targeted by human-specific virulence 481 factors by generating a transgenic zebrafish line expressing C5AR1 on the neutrophil surface. 482
These fish become significantly more susceptible to staphylococcal infection due to targeting 483 by pore-forming leukocidins PVL and HlgCB, suggesting that humanisation of the zebrafish 484 model to confer sensitivity to human-specific virulence factors is a viable approach for studying 485 pathogenicity. Finally, we produced a signalling dreC5aR variant with only three amino acid 486 substitutions that is targeted by the human-specific virulence factor CHIPS, suggesting that a 487 partially humanised infection model is also a viable approach to studying pathogenesis in this 488 model. 489 vector control (Con), the wild type dreC5aR (WT), or the dreC5aR variants described in (A), 796 assessed by measuring calcium mobilisation by flow cytometry using the fluorescent probe 797
Fluo-3AM following incubation with 3.3 μM recombinant His-dreC5a. Data is presented as 798 relative fluorescent signal compared to the wild type U937-dreC5aR (WT, set at 100%). C) 799
C5aR activity determined as in (b) following incubation with 3.3 μM recombinant His-dreC5a 800 in the absence or presence of 10 μg/ml recombinant CHIPS presented as percentage 801
